PE20011041A1 - PIRAZOLO[4,3-e]DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN Y PROCESOS PARA PREPARARLAS - Google Patents
PIRAZOLO[4,3-e]DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN Y PROCESOS PARA PREPARARLASInfo
- Publication number
- PE20011041A1 PE20011041A1 PE2001000003A PE2001000003A PE20011041A1 PE 20011041 A1 PE20011041 A1 PE 20011041A1 PE 2001000003 A PE2001000003 A PE 2001000003A PE 2001000003 A PE2001000003 A PE 2001000003A PE 20011041 A1 PE20011041 A1 PE 20011041A1
- Authority
- PE
- Peru
- Prior art keywords
- cycloalkyl
- alkyl
- pirazolo
- diazepines
- prepare
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I DONDE R1 ES H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ALQUILCICLOALQUILO C1-C6, ARILO C5-C10, ARILALQUILO C6-C10, ENTRE OTROS; R2 ES ALQUILO C1-C6, ALQUILCICLOALQUILO C1-C6, CICLOALQUILO C3-C6, ARILO C5-C10 CON HETEROATOMOS, ENTRE OTROS; R3 ES H, ALQUILO C1-C6, CICLOALQUILO C3-C6, ARILO C5-C10, ARILALQUILO C6-C10, ENTRE OTROS; LA UNION ENTRE W Y C EN LA POSICION 5 PUEDE SER UNA SOLA UNION EN CUYO CASO W ES N SUSTITUIDO CON H O UNA UNION DOBLE EN ESE CASO W ES C NO SUSTITUIDO; X ES S, O, N-CN, ENTRE OTROS. SON COMPUESTOS PREFERIDOS 1-ETIL-5-(4-METOXIFENIL)-3-METIL-6,7-DIHIDRO-1H-PIRAZOLO[4,3-e][1,4]DIAZEPIN-8-ONA, 5-(4-BROMOFENIL)-1-ETIL-3-METIL-6,7-DIHIDRO-1H-PIRAZOLO[4,3-e][1,4]DIAZEPIN-8-ONA, ENTRE OTROS.SE REFIERE TAMBIEN A UN PROCEDIMIENTO PARA LA PREPARACION Y A COMPUESTOS INTERMEDIOS. LOS COMPUESTOS DE FORMULA I SON INHIBIDORES SELECTIVOS DE LA FOSFODIESTERASA PDE4 POR LO QUE PUEDEN SER UTILES EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS, CANCER, FIBROSIS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0000095A FR2803299B1 (fr) | 2000-01-05 | 2000-01-05 | NOUVELLES PYRAZOLO [4,3-e] DIAZEPINES SUBSTITUEES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20011041A1 true PE20011041A1 (es) | 2001-10-12 |
Family
ID=8845641
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000003A PE20011041A1 (es) | 2000-01-05 | 2001-01-03 | PIRAZOLO[4,3-e]DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN Y PROCESOS PARA PREPARARLAS |
Country Status (42)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1188438A1 (en) * | 2000-09-15 | 2002-03-20 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production |
| EP1199074A1 (en) * | 2000-09-15 | 2002-04-24 | Warner-Lambert Company | Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production |
| AR058071A1 (es) * | 2005-10-03 | 2008-01-23 | Astrazeneca Ab | Derivados de dihidropirazolo (3,4-e)(1,4)diazepina. procesos de obtencion y composiciones farmaceuticas. |
| KR20160080799A (ko) | 2014-12-30 | 2016-07-08 | 한국해양과학기술원 | 금 촉매를 이용한 α-피론 유도체 전합성 방법 및 이에 의해 합성되어 인간 암세포주에 세포독성을 가지는 α-피론 유도체 |
| WO2018108230A1 (en) | 2016-12-12 | 2018-06-21 | Leo Pharma A/S | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
| US11065257B2 (en) | 2016-12-12 | 2021-07-20 | Leo Pharma A/S | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors |
| CN110099905A (zh) | 2016-12-12 | 2019-08-06 | 利奥制药有限公司 | 取代的吡唑并氮杂*-8-酮类及其作为磷酸二酯酶抑制剂的用途 |
| TWI812739B (zh) * | 2018-06-21 | 2023-08-21 | 景凱生物科技股份有限公司 | Nadph氧化酶抑制劑、含其的醫藥組合物、及其應用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3764688A (en) * | 1972-07-27 | 1973-10-09 | Abbott Lab | 4,6-DIHYDRO-1,3-DIMETHYL-8-PHENYL-4-PROPARGYL-PYRAZOLO {8 4,3-e{9 {0 DIAZEPIN-5 (1H) ONE IN TREATING INFLAMMATION |
-
2000
- 2000-01-05 FR FR0000095A patent/FR2803299B1/fr not_active Expired - Fee Related
- 2000-12-23 DZ DZ000158A patent/DZ3103A1/xx active
- 2000-12-27 SK SK940-2002A patent/SK9402002A3/sk unknown
- 2000-12-27 KR KR1020027008692A patent/KR20020063293A/ko not_active Application Discontinuation
- 2000-12-27 IL IL15039400A patent/IL150394A0/xx unknown
- 2000-12-27 CA CA002396315A patent/CA2396315A1/en not_active Abandoned
- 2000-12-27 AP APAP/P/2002/002572A patent/AP2002002572A0/en unknown
- 2000-12-27 HU HU0204213A patent/HUP0204213A2/hu unknown
- 2000-12-27 DE DE60014712T patent/DE60014712T2/de not_active Expired - Fee Related
- 2000-12-27 JP JP2001550229A patent/JP2003519233A/ja active Pending
- 2000-12-27 TR TR2002/01719T patent/TR200201719T2/xx unknown
- 2000-12-27 WO PCT/EP2000/013380 patent/WO2001049689A2/en active Search and Examination
- 2000-12-27 AU AU33678/01A patent/AU3367801A/en not_active Abandoned
- 2000-12-27 PL PL00356668A patent/PL356668A1/xx not_active Application Discontinuation
- 2000-12-27 ES ES00991657T patent/ES2226978T3/es not_active Expired - Lifetime
- 2000-12-27 BR BR0016926-9A patent/BR0016926A/pt not_active Application Discontinuation
- 2000-12-27 EP EP00991657A patent/EP1248787B1/en not_active Expired - Lifetime
- 2000-12-27 CN CN00818202A patent/CN1420888A/zh active Pending
- 2000-12-27 MX MXPA02006618A patent/MXPA02006618A/es active IP Right Grant
- 2000-12-27 NZ NZ519520A patent/NZ519520A/en unknown
- 2000-12-27 EE EEP200200373A patent/EE200200373A/xx unknown
- 2000-12-27 AT AT00991657T patent/ATE278692T1/de not_active IP Right Cessation
- 2000-12-27 OA OA1200200203A patent/OA12134A/en unknown
- 2000-12-27 CZ CZ20022222A patent/CZ20022222A3/cs unknown
- 2000-12-27 EA EA200200610A patent/EA005071B1/ru not_active IP Right Cessation
-
2001
- 2001-01-03 TN TNTNSN01001A patent/TNSN01001A1/fr unknown
- 2001-01-03 PA PA20018509601A patent/PA8509601A1/es unknown
- 2001-01-03 PE PE2001000003A patent/PE20011041A1/es not_active Application Discontinuation
- 2001-01-03 UY UY26517A patent/UY26517A1/es not_active Application Discontinuation
- 2001-01-03 AR ARP010100024A patent/AR032298A1/es not_active Application Discontinuation
- 2001-01-04 GT GT200100002A patent/GT200100002A/es unknown
- 2001-01-04 CO CO01000514A patent/CO5290255A1/es not_active Application Discontinuation
- 2001-01-04 SV SV2001000253A patent/SV2001000253A/es not_active Application Discontinuation
- 2001-01-04 HN HN2001000002A patent/HN2001000002A/es unknown
-
2002
- 2002-06-19 IS IS6437A patent/IS6437A/is unknown
- 2002-07-01 CR CR6693A patent/CR6693A/es not_active Application Discontinuation
- 2002-07-02 ZA ZA200205287A patent/ZA200205287B/en unknown
- 2002-07-02 BG BG106893A patent/BG106893A/xx unknown
- 2002-07-03 MA MA26719A patent/MA26863A1/fr unknown
- 2002-07-04 NO NO20023249A patent/NO20023249L/no not_active Application Discontinuation
- 2002-07-05 HR HR20020577A patent/HRP20020577A2/hr not_active Application Discontinuation
-
2003
- 2003-03-24 HK HK03102129.7A patent/HK1050002A1/zh unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY128479A (en) | (beta)-carboline derivatives useful as inhibitors of phosphodiesterase | |
| MY126917A (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| YU16899A (sh) | Aralkil i aralkiliden heterociklicni laktami i imidi | |
| ES2175624T3 (es) | Derivados de pirazolo(4,3-d)pirimidina y composiciones farmaceuticas que los contienen. | |
| DK1278735T3 (da) | 2,4-di(hetero-)arylamino(-oxy)-5-substituerede pyrimidiner som antineoplastiske midler | |
| NO20056192L (no) | Kapaseinhibitorer og anvendelse derav | |
| CR6881A (es) | Derivados de pirazol | |
| NO20073393L (no) | [1,2,4]tnazolo [4,3-A] pyridin derivater for behandlingen av hyperproliferative sykdommer | |
| EA200300248A1 (ru) | Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции | |
| NO20035583D0 (no) | Imidazo` 1,2-A pyridinderivater for profylakse og behandling av herpes virale infeksjoner | |
| SV2003001173A (es) | 1-alquil o 1-cicloalquil-triazolo [4,3-a] quinazolin-5- onas como inhibidoras de fosfodiesterasa | |
| PE20021085A1 (es) | PIRROLO (2.1-a) DIHIDROISOQUINOLINAS | |
| ATE300541T1 (de) | Pyrazolopyridinderivate | |
| IL151201A0 (en) | Alkylated imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| SE9701304D0 (sv) | Compounds | |
| PE20011041A1 (es) | PIRAZOLO[4,3-e]DIAZEPINAS SUSTITUIDAS NOVEDOSAS, COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN Y PROCESOS PARA PREPARARLAS | |
| IL151200A0 (en) | Tricyclic imidazopyridine prodrug derivatives and pharmaceutical compositions containing the same | |
| WO2003028721A3 (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
| WO2005035537A3 (en) | Substituted tricyclic heterocycles and their uses | |
| TR200101978T2 (tr) | 3,3-Biarilpiperidin ve 2,2-biarilmorfolin türevleri. | |
| IL151198A0 (en) | Tricyclic imidazopyridine derivatives and pharmaceutical compositions containing the same | |
| HUP0401588A2 (hu) | Rákellenes és proliferáció elleni hatású indeno[1,2-c]pirazol-4-on-származékok és ezeket tartalmazó gyógyszerkészítmények | |
| NO20055749L (no) | Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |